Compass Therapeutics, Inc.
CMPX · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Lerner Neil: Form 4
Insider disclosure · Filed · Report period 01 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CMPX · 20454B104 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001738021 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CMPX on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 80 Guest Street, Boston, MA, 02135
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Olivia Ventures, Inc. (to 08 Jun 2020)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields